Patient outcome and valve performance following a second aortic valve homograft replacement

Circulation

Volumn 100, Issue 19 SUPPL., 1999, Pages

  Hasnat, K ^a   Birks, E J ^a   Liddicoat, J ^a   Hon, J K F ^a   Edwards, S ^a   Glennon, S ^a   Yacoub, Magdi H ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Aorta; Regurgitation; Valves

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGRAFT; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; FEMALE; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTHESIS FAILURE; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0345073281     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.100.suppl_2.ii-42     Document Type: Article

References (22)

1. Ross DN, Yacoub MH. Homograft replacement of the aortic valve: a critical review. Prog Cardiovasc Dis. 1969;11:275-293.
2. Barratt-Boyes BG, Roche AH, Subramanyan R, Pemberton JR, Whitlock RM. Long-term follow-up of patients with the antibiotic-sterilized aortic homograft valve inserted freehand in the aortic position. Circulation. 1987;75:768-777.
3. O'Brien MF, McGiffin DC, Stafford EG. Allograft aortic valve replacement long term comparative clinical analysis of the viable cryopreserved and antibiotic 4c stored valves. J Cardiac Surgery. 1991;6:534-563.
4. Yacoub M, Rasmi NR, Sundt TM, Lund O, Boyland E, Radley-Smith R, Khaghani A, Mitchell A. Fourteen-year experience with homovital homografts for aortic valve replacement. J Thorac Cardiovasc Surg. 1995;110:186-193.
5. Lund O, Chadrasekeran V, Grocott-Mason R, Elwida H, Mahzhar R, Khaghani A, Mitchell A, Ilsley C, Yacoub MH. Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg. 1999;117:77-90.
6. Yacoub MH, Suitters A, Khaghani A, Rose ML. Localisation of major histocompatibility complex antigens in aortic homografts. In Biologic and Bioprosthetic Valves: Proceedings of the Third International Symposium. New York, NY: York Medical Books; 1986:63-72.
7. Smith JD, Ogino H, Hunt D, Laylor RM, Rose ML, Yacoub MH. Humoral immune response to human aortic valve homografts. Ann Thorac Surg. 1995;60:S127-S130.
8. Edmunds LH Jr, Clark RE, Cohn LH, Miller G. Guidelines for reporting morbidity and mortality after cardiac valve operations. Ann Thorac Surg. 1988;46:257-259.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete information. J Am Stat Assoc. 1958;53:457-481.
10. Cox DR, Oakes D. Multivariate analysis. In: Cox DR, Oakes D. eds. Analysis of Survival Data. London, England: Chapman and Hall. 1984:64.
11. Kirklin JW, Barratt-Boyes BG. Aortic valve disease. In: Kirklin JW, Barratt-Boyes BG, eds. Cardiac Surgery. 2nd ed. New York, NY: Churchill-Livingstone; 1992:491-557.
12. McGiffin DC, O'Brien MF, Stafford EG, Gardner MA, Pohlner PG. Long-term results of the viable cryopreserved allograft aortic valve: continuing evidence for superior valve durability. J Card Surg. 1988;3:289-296.
13. Albertucci M, Wong K, Petrou M, Mitchell A, Somerville J, Theodoropolous S, Yacoub M. The use of unstented homograft valves for aortic valve reoperations. J Thorac Cardiovasc Surg. 1994;107:152-161.
14. Cohn LH, Aranki SF, Rizzo RJ, Adams DH, Cogswell KA, Kinchla NM, Couper GS, Collins JJ Jr. Decrease in operative risk of reoperative valve surgery. Ann Thorac Surg. 1993;56:15-20.
15. Morishita K, Mawatari T, Baba T, Fukada J, Abe T. Re-replacement for prosthetic valve dysfunction: analysis of long-term results and risk factors. Ann Thorac Surg. 1998;65:696-699.
16. Parr GV, Kirklin JW, Blackstone EH. The early risk of re-replacement of aortic valves. Ann Thorac Surg. 1977;23:319-322.
17. Wideman FE, Blackstone EH, Kirklin JW, Karp RB, Kouchoukos NT, Pacifico AD. Hospital mortality of re-replacement of the aortic valve: incremental risk factors. J Thorac Cardiovasc Surg. 1981;82: 692-698.
18. Kawachi Y, Matuzaki K, Tominaga R, Yasui H, Tokunuga K. The risks of reoperation for prosthetic valve dysfunction. Surg Today. 1994;24:415-419.
19. Bosch X, Pomar JL, Pelletier LC. Early and late prognosis after reoperation for prosthetic valve replacement. J Thorac Cardiovasc Surg. 1984;88:567-572.
20. Yankah AC, Wottge HU, Muller-Ruchholtz W. Prognostic importance of viability and a study of a second set allograft valve: an experimental study. J Card Surg. 1988;3:263-270.
21. Yacoub MH. Applications and limitations of histocompatibility in clinical cardiac valve allograft surgery. Cardiac Valve Allograft, 1962-1987. New York, NY: Springer-Verlag: 1988:95.
22. Smith JD, Hornick PI, Rasmi N, Rose ML, Yacoub MM. Effect of HLA mismatching and antibody status on "homovital" aortic valve homograft performance. Ann Thorac Surg. 1998;66(6 suppl):5212-5215.